2023 Session Recordings Listing

When possible, sessions presented at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, held July 23 – 27, 2023, are available as part of the 2023 Session Recordings. The listing of specific recordings included in the full 2023 Session Recordings is below. Please note that 2023 Session Recordings are not eligible for continuing education credit.


2023 Session Recordings will be accessible starting August 29, 2023 and accessible through July 31, 2024.

Individuals that have purchased or been given complimentary access will be notified by email when recording are available. To access already purchased recordings, visit the recordings site and log in using ADLM credentials.

Individuals who did not previously purchase the recordings or attend the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo as an ADLM member with Anaheim All Access registration may purchase the session recordings for access.


PLENARY AND MEET-THE-EXPERT SESSIONS

11001 Developing Microbiome-Directed Therapeutics for Treating Childhood Undernutrition
Wallace H. Coulter Award Lectureship
Jeffrey Gordon, MD, Washington University School of Medicine, St. Louis, MO

62001 Developing Microbiome-Directed Therapeutics for Treating Childhood Undernutrition
Meet the Expert Session

Jeffrey Gordon, MD, Washington University School of Medicine, St. Louis, MO

12001 Precisely Practicing Medicine from 700 Trillion Points of Data
Atul Butte, MD, PhD, University of California, San Francisco/University of California Health, San Francisco, CA

13001 Choosing Equity in Healthcare: An Organizational Transformation
Thea James, MD, MPH, MBA, Boston Medical Center, Boston, MA

14001 Cardiovascular Disease in Women: Epidemiology, Awareness, Access, and Delivery of Equitable Health Care
Nanette Wenger, MD, MACC, MACP, FAHA, Emory University School of Medicine, Atlanta, GA

15001 Advances in Curative Therapies for Sickle Cell Disease
Mark Walters, MD, University of California, San Francisco/Benioff Children's Hospital Oakland, Oakland, CA

SPECIAL SESSIONS

12002 Disruptive Technology Award Competition
DTAC
Moderator: Stephen Master, MD, PhD, FAACC, Children's Hospital of Philadelphia, Philadelphia, PA
Speaker(s):

  • Carey-Ann Burnham, PhD, Chief Clinical Officer, Pattern Bioscience
  • Livia Eberlin, PhD, Chief Scientific Officer, MS Pen Technologies, Inc.
  • Mounir Koussa, PhD, Co-founder and Vice President of R&D, Vital Biosciences, Inc.

32102 Emerging Trends in Laboratory Medicine: Excellence from the Global Community
President Invited Session
Moderator: Shannon Haymond, PhD, DABCC, FAACC, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
Speaker(s):

  • Rapid Response Processes for Emerging Infectious Diseases: Importance of Preparedness and Collaboration
    Heungsup Sung, MD, PhD, University of Ulsan College of Medicine, Seoul (Republic of Korea)
  • Appropriate Test Utilization Driving Sustainability
    Katherine Hayden, FRCPath, CSci, EuSpLM, BSc, Association for Clinical Biochemistry and Laboratory Medicine, Manchester (United Kingdom)
  • Machine Learning Guidelines for the Global Laboratory Medicine Community
    Stephen Master, MD, PhD, FAACC, Children's Hospital of Philadelphia, Philadelphia, PA

32442 High-Sensitivity Cardiac Troponin: Updates on Educational Recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers
AMOC Chair Invited Session
Moderator: Amy Saenger, PhD, DABCC, FAACC, Hennepin County Medical Center, Minneapolis, MN
Speaker(s):

  • How Did Laboratory and Clinical Practice Get to Cardiac Troponin I and T: Is One Assay Superior to the Other?
    Peter Kavsak, PhD, FCACB, FAACC, FCCS, McMaster University, Hamilton, ON (Canada)
  • High-Sensitivity Troponin for Early Rule-Out of Myocardial Infarction
    Allan Jaffe, MD, Mayo Clinic, Rochester, MN
  • Analytical Nuances with High-Sensitivity Troponin Assays: From the 99th Percentile to Macrotroponin
    Kristin Aakre, MD, PhD, Haukeland University Hospital, Bergen (Norway)
  • Updated Recommendations for Utilization of Point-of-Care Cardiac Troponin Assays
    Louise Cullen, MBBS(Hon), FACEM, PhD, Royal Brisbane and Women’s Hospital/The University of Queensland, Brisbane (Australia)

SCIENTIFIC SESSIONS

32101 Communication as a Mechanism for Building and Keeping Teams Effective (permission withheld by speakers)
Moderator: Sara Love, PhD, DABCC, Siemens Healthineers, Newark, DE
Speaker(s):

  • Disengagement, Burnout, and Turnover in Laboratory Medicine
    Sara Love, PhD, DABCC, Siemens Healthineers, Newark, DE
  • Giving a Gift of Improv for Improv-ing Communication
    Jim Robinson, Consultant, Saint Paul, MN

32103 The Pathology Informatics Service: A Model for Laboratory Improvement and Education
Moderator: Ronald Jackups, MD, PhD, Washington University in St. Louis, Saint Louis, MO
Speaker(s):

  • Pathology Informatics Service at Washington University in St. Louis
    Ronald Jackups, MD, PhD, Washington University in St. Louis, Saint Louis, MO
  • Pathology Informatics Service at the University of Washington
    Noah Hoffman, MD, PhD, University of Washington, Seattle, WA
  • Pathology Informatics Service at Houston Methodist Hospital
    Paul Christensen, MD, Houston Methodist Hospital, Houston, TX

32104 Spanning the Spectrum from Pre- To Post-analytical Effects on Blood Gas Analysis: Updated Guidelines and Challenges in Modern Medicine among Different Patient Populations
Moderator: J Shirley Li, MD, PhD, DABCC, NRCC, FCACB, The Ohio State University Wexner Medical Center, Columbus, OH
Speaker(s):

  • New Preanalytical Challenges in Blood Gas Analysis in Modern Medicine and Different Patient Populations
    Felix Leung, PhD, FCACB, Mount Sinai Hospital, Toronto, ON (Canada)
  • New Post-analytical Challenges in Blood Gas Analysis in Different Medical Conditions
    J Shirley Li, MD, PhD, DABCC, NRCC, FCACB, The Ohio State University Wexner Medical Center, Columbus, OH
  • Interesting Tidbits and Controversies in Developing the New 3rd Edition of CLSI C46: Blood Gas and pH Analysis and Related Measurements
    John Toffaletti, PhD, DABCC, Duke University Medical Center, Durham, NC

32105 Sepsis: Clinical Updates and Emerging Diagnostic Markers
Moderator: Xiaochun Zhang, MD, PhD, DABCC, DABMLI, HCLD, University Hospitals Cleveland Medical Center, Cleveland, OH
Speaker(s):

  • The New Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021 in Practice
    Layla Sankari, MD, University Hospitals Cleveland Medical Center, Cleveland, OH
  • Emerging New Biomarkers for Sepsis: Ready for Implementing?
    Xiaochun Zhang, MD, PhD, DABCC, DABMLI, HCLD, University Hospitals Cleveland Medical Center, Cleveland, OH

32106 Interpretation of Pediatric Toxicology Results in the Assessment of Child Maltreatment
Moderator: Kara Lynch, PhD, DABCC, FAACC, University of California, San Francisco, San Francisco, CA
Speaker(s):

  • Child Maltreatment Evaluations in the Setting of Positive Toxicology Results
    Kelsey Merl, NP, MPH, University of California, San Francisco/Benioff Children's Hospital Oakland, Oakland, CA
  • Pediatric Toxicology: Analytical Approaches and Clinical Cases
    Kara Lynch, PhD, DABCC, FAACC, University of California, San Francisco, San Francisco, CA

32107 Representation Matters: The Importance of Gender Diversity from the Bench to the Bedside (permission withheld by speakers)
Moderator: Dina Greene, PhD, DABCC, LetsGetChecked, Burien, WA
Speaker(s):

  • The Chemist’s Perspectives
    Dina Greene, PhD, DABCC, LetsGetChecked, Burien, WA
  • The Trialist’s Perspective
    Mark Marzinke, PhD, DABCC, FAACC, Johns Hopkins University, Baltimore, MD
  • The Practitioner’s Perspective
    Zil Goldstein, FNP-BC, AAHIVS, Callen-Lorde, New York, NY

32108 Hyperglycemia in the Hospital: Are Our Tools for Measurement Accurate Enough?
Moderator: David Sacks, MB, ChB, FRCPath, National Institutes of Health, Bethesda, MD
Speaker(s):

  • What Should Glucose Targets Be in the Hospital?
    Mary Korytkowski, MD, University of Pittsburgh, Pittsburgh, PA
  • Blood Glucose Meters in the Hospital: Are They Good Enough?
    David Sacks, MB, ChB, FRCPath, National Institutes of Health, Bethesda, MD
  • Continuous Glucose Monitors in the Hospital: Are They Good Enough?
    Guido Freckmann, MD, Institute for Diabetes Technology GmbH, Ulm, Germany, Ulm (Germany)

32109 Hype, Hope, or Already Here: The Status of Non-Invasive Prenatal Screening and Liquid Biopsies
Moderator: Vera Paulson, MD, PhD, University of Washington, Kirkland, WA
Speaker(s):

  • cfDNA in Prenatal Screening and Diagnosis
    Christina Lockwood, PhD, DABCC, DABMGG, University of Washington, Seattle, WA
  • cfDNA in Tumor Testing
    Vera Paulson, MD, PhD, University of Washington, Kirkland, WA

32221 Calculated LDL-Cholesterol: Quo Vadis
Moderator: Tahir Pillay, MD, PhD, University of Pretoria/National Health Laboratory Service, Pretoria (South Africa)
Speaker(s):

  • What is the Best Practice in LDL-Cholesterol? When and How to Calculate
    Tahir Pillay, MD, PhD, University of Pretoria/National Health Laboratory Service, Pretoria (South Africa)
  • Risk Assessment in Cardiovascular Disease Using Derived Lipid Profile Parameters
    Patrick Twomey, MB BCH BAO, FRCPath, FFPath(RCPI), FRCPI, St Vincent's University Hospital, Dublin (Ireland)

32222 Advances in Courier, Drone, and Automated Laboratory Transport
Moderator: Joe Wiencek, PhD, DABCC, NRCC, FAACC, Vanderbilt University School of Medicine, Nashville, TN
Speaker(s):

  • Mitigating Environmental Factors on Specimens by Standardizing Courier Transport Systems
    Joe Wiencek, PhD, DABCC, NRCC, FAACC, Vanderbilt University School of Medicine, Nashville, TN
  • Drones are Expanding the Horizon of Specimen Transport Systems
    Timothy Amukele, MD, PhD, ICON Clinical Research, Farmingdale, MD
  • Maximizing Efficiency in Processing and Specimen Distribution through Laboratory Automation
    Jonathan Genzen, MD, PhD, ARUP Laboratories, Salt Lake City, UT

32223 Interactive Patient Case Presentation: A Discussion Between Laboratory Medicine, Cardiology, and Emergency Medicine Providers Addressing Utilization of High Sensitivity Cardiac Troponin Assays in Clinical Practice
Moderator: Peter Kavsak, PhD, FCACB, FAACC, FCCS, McMaster University, Hamilton, ON (Canada)
Speaker(s):

  • Laboratory Medicine Experience
    Peter Kavsak, PhD, FCACB, FAACC, FCCS, McMaster University, Hamilton, ON (Canada)
  • Emergency Medicine Experience
    Louise Cullen, MBBS(Hon), FACEM, PhD, Royal Brisbane and Women’s Hospital/The University of Queensland, Brisbane (Australia)
  • Cardiology Experience
    Allan Jaffe, MD, Mayo Clinic, Rochester, MN

32224 To Immunoassay or To Mass Spec: Lab Stewardship Questions When Bringing Antiepileptic Drug Assays In-House
Moderator: Adina Badea, PhD, DABCC, Lifespan Health/Rhode Island Hospital/Brown University, Providence, RI
Speaker(s):

  • Creating Clinical Value with Low-Volume Immunoassays Testing
    Claire Knezevic, PhD, DABCC, NRCC, Johns Hopkins Medical Institutes, Baltimore, MD
  • Meeting Clinical Needs and Decreasing Sendout Costs with Mass Spectrometry Testing
    Alec Saitman, PhD, ASCP, DABCC, Providence Regional Laboratories, Portland, OR
  • Meeting Turnaround-Time Expectations with Flexible Scheduling in Mass Spectrometry Testing
    Adina Badea, PhD, DABCC, Lifespan Health/Rhode Island Hospital/Brown University, Providence, RI

32225 Assessing Kidney Function by mGFR and eGFR: Current and Future Approaches
Moderator: Joe El-Khoury, PhD, DABCC, FAACC, Yale University, West Haven, CT
Speaker(s):

  • Directly Measuring Patients’ GFR in Routine Clinical Practice
    Jesse Seegmiller, PhD, DABCC, University of Minnesota, Farmington, MN
  • Looking to the Future of Serum Creatinine and eGFR in Assessing Chronic Kidney Disease
    John Toffaletti, PhD, DABCC, Duke University Medical Center, Durham, NC

32226 Person-Centered Care for Opioid Use Disorder: Shifting Roles for Clinical Laboratories and Urine Drug Testing (permission withheld by speakers)
Moderator: Danijela Konforte, PhD, FCACB, LifeLabs, Toronto, ON (Canada)
Speaker(s):

  • Clinical Use of Urine Drug Testing in the Context of Patient-Centered Opioid Use Disorder Management
    Danijela Konforte, PhD, FCACB, LifeLabs, Toronto, ON (Canada)
  • Harm Reduction Services and the Clinical Laboratory: An Important Collaboration to Optimize Care
    Danijela Konforte, PhD, FCACB, LifeLabs, Toronto, ON (Canada)

32227 Leprosy: Diagnostic Challenges in the Endemic Country of Brazil
Moderator: John Spencer, PhD, Colorado State University, Fort Collins, CO
Speaker(s):

  • Laboratory Tests Used to Support the Clinical Diagnosis of Leprosy
    John Spencer, PhD, Colorado State University, Fort Collins, CO
  • Active Leprosy Surveillance and Diagnosis Based on Clinical Signs and Symptoms: A 13 Year History of Leprosy in the Brazilian Amazon
    Claudio Salgado, MD, PhD, Ministry of Health of Brazil and Federal University of Pará, Belém, Pará (Brazil)

32228 Stronger Together: Eliminating Racial Healthcare Inequities by Mitigating Systemic Racism
Moderator: Christina Pierre, PhD, DABCC, Lancaster General Hospital, Lancaster, PA
Speaker(s):

  • Actions to Transform US Preventive Services Task Force Methods to Mitigate Systemic Racism in Clinical Preventive Services
    Esa Davis, MD, MPH, FAAFP, University of Pittsburgh Medical Center, Pittsburg, PA
  • A Review of the AACC-NKF Guidance Document on Chronic Kidney Disease Diagnosis: Improving Equity in Chronic Kidney Disease
    Christina Pierre, PhD, DABCC, Lancaster General Hospital, Lancaster, PA
  • Centering Laboratory Medicine: Designing Your Organizations Health Equity Playbook
    Octavia Peck Palmer, PhD, FAACC, University of Pittsburgh Medical Center, Pittsburgh, PA

32229 Risky Business: Mitigation Strategies for FDA-Modified and LDT Assays Using Alternate Specimen Types
Moderator: Jane Dickerson, PhD, DABCC, Seattle Children's Hospital, Seattle, WA
Speaker(s):

  • All the Right Moves: Body Fluid Validation Made Accessible
    Steven Cotten, PhD, DABCC, NRCC, FAACC, University of North Carolina at Chapel Hill, Chapel Hill, NC
  • War of the Worlds: Inpatient Needs in the Outpatient Setting
    Jane Dickerson, PhD, DABCC, Seattle Children's Hospital, Seattle, WA

32441 Project Management in Laboratory Medicine: Principles and Applications in Large and Small Laboratories
Moderator: Brad Karon, MD, PhD, FAACC, Mayo Clinic, Rochester, MN
Speaker(s):

  • Project Management: What Is It, and Why Is It Important in the Laboratory?
    Mary Jo Abel, PMP, Mayo Clinic, Rochester, MN
  • Project Management in a Large Laboratory System
    Earle Collum, MD, FCAP, Labcorp, Phoenix, AZ
  • Project Management in Community Hospital Laboratories and Urgent Care Centers
    Kendall Cradic, PhD, OhioHealth Laboratory Services, Powell, OH

32443 Genomic Testing and the Complexity of Introducing Emerging Technologies in Laboratory Medicine
Moderator: Lianna Kyriakopoulou, PhD, Hospital for Sick Children, Toronto, ON (Canada)
Speaker(s):

  • Emerging Technologies: A Definition for Laboratory Medicine and Their Role in Healthcare Worldwide
    Ronda Greaves, PhD, Victorian Clinical Genetics Services, Parkville, VIC (Australia)
  • The Evolving Role of Emerging Genomic Technologies in Laboratory Medicine
    Lianna Kyriakopoulou, PhD, Hospital for Sick Children, Toronto, ON (Canada)

32444 Advances in Biomarkers of Transplant Rejection
Moderator: Loralie Langman, PhD, DABCC, Mayo Clinic, Rochester, MN
Speaker(s):

  • Transplant Rejection: HLA Eplets and Antibody Testing
    Manish Gandhi, MD, Mayo Clinic, Rochester, MN
  • Donor Derived Cell Free DNA (dd-cfDNA) as a Biomarker in Solid Organ Transplantation
    Stephen Murphy, PhD, Mayo Clinic, Rochester, MN

32445 Bridging Emergency Medicine and Public Health: Clinical Toxicology Laboratory Strategies to Characterize Local Drug Supplies and Drug Use Patterns
Moderator: Adina Badea, PhD, DABCC, Lifespan Health/Rhode Island Hospital/Brown University, Providence, RI
Speaker(s):

  • Using Qualitative and Ethnographic Research Methods to Assess Shifts in Drug Supplies and Use Patterns
    Alexandra Collins, PhD, Brown University School of Public Health, Providence, RI
  • Tiered Toxicology Testing to Characterize Local Drug Supply and Overdose Culprits
    Adina Badea, PhD, DABCC, Lifespan Health/Rhode Island Hospital/Brown University, Providence, RI
  • Toxicology Results Interpretation and Effective Communication for Timely Individual and Community Response
    Rachel Wightman, MD, FACMT, Alpert Medical School of Brown University, Providence, RI

32446 An Update on Complement Testing in the Era of Complement Therapeutics
Moderator: Vijayalakshmi (Viji) Nandakumar, PhD, DABCC, ARUP Laboratories/University of Utah School of Medicine, Salt Lake City, UT
Speaker(s):

  • Advancements and Nuances in Complement Testing in the Clinical Laboratory
    Ashley Frazer-Abel, PhD, DABMLI, University of Colorado School of Medicine/Exsera BioLabs, Aurora, CO
  • Monitoring of Anti-complement Therapeutics in Complement-Mediated Renal Diseases
    Vijayalakshmi (Viji) Nandakumar, PhD, DABCC, ARUP Laboratories/University of Utah School of Medicine, Salt Lake City, UT

32447 Cystic Fibrosis: Treatment, Diagnosis, and Laboratory Best Practices
Moderator: Stanley Lo, PhD, DABCC, FAACC, Children's Wisconsin, Milwaukee, WI
Speaker(s):

  • Overview of Cystic Fibrosis Diagnosis and Management
    Clement Ren, MD, MBA, Children's Hospital of Philadelphia, Philadelphia, PA
  • Sweating the Small Stuff: Best Practices for Sweat Testing to Diagnose Cystic Fibrosis
    Edith Zemanick, MD MSCS, University of Colorado and Children's Hospital Colorado, Aurura, CO

32448 Artificial Intelligence and Machine Learning in the Clinical Laboratories: Fundamental Concepts, Clinical Use Cases, and Future Considerations
Moderator: David McClintock, MD, Mayo Clinic, Rochester, MN
Speaker(s):

  • Foundational Concepts of Analytics, Artificial Intelligence, and Machine Learning
    Christopher Williams, MD, EE, University of Oklahoma Health Sciences Center, Oklahoma City, OK
  • Artificial Intelligence and Machine Learning Use in the Clinical Laboratories
    David McClintock, MD, Mayo Clinic, Rochester, MN
  • Future Considerations for Artificial Intelligence and Machine Learning in the Clinical Laboratories: A Focus on Ethics, Regulatory, and Data Governance
    Thomas Durant, MD, Yale School of Medicine, Wallingford, CT

33101 Risk-Based Quality Control: Changing the Way We Do Quality Control
Moderator: Joseph Rudolf, MD, ARUP Laboratories/University of Utah School of Medicine, Salt Lake City, UT
Speaker(s):

  • A Simple Tutorial on Risk-Based Analysis for Quality Control
    Robert Schmidt, MD, PhD, MBA, Labcorp, Burlington, NC
  • Precision Quality Control: A Risk-Based Model to Support Quality Control Decisions
    Joseph Rudolf, MD, ARUP Laboratories/University of Utah School of Medicine, Salt Lake City, UT

33102 Decoding Molecular Signatures in Cancer Diagnostics
Moderator: Jude Abadie, PhD, DABCC, DABMGG, FAACC, FACMG, Texas Tech University Health Sciences Center, El Paso, TX
Speaker(s):

  • Profiling Molecular Signatures That Define Tumorigenesis
    Jude Abadie, PhD, DABCC, DABMGG, FAACC, FACMG, Texas Tech University Health Sciences Center, El Paso, TX
  • Mutation Signatures in Hematologic Malignancies and Solid Tumors
    Vera Paulson, MD, PhD, University of Washington, Kirkland, WA

33103 A Roadmap to Successful Data Analytics Projects at your Institution Today and in the Future
Moderator: Thomas Durant, MD, Yale School of Medicine, Wallingford, CT
Speaker(s):

  • The ABCs of Data Analytics in the Laboratory: Tackling Complexity with Confidence
    Thomas Durant, MD, Yale School of Medicine, Wallingford, CT
  • Practical Use of Data to Guide Decision Making in the Clinical Laboratory
    David Peaper, MD, PhD, Yale School of Medicine, New Haven, CT
  • Taking Laboratory Analytics to the Next Level: Development of Purpose-Built Infrastructure and Resources to Fuel Improved Laboratory Medicine
    Patrick Mathias, MD, PhD, University of Washington School of Medicine, Seattle, WA

33104 AACC Healthcare Forum: Meeting the 21st Century Needs of the Laboratory Workforce
Moderator: Vince Stine, PhD, AACC, Washington, DC
Speaker(s):

  • The Personnel Crisis and What it Means for Clinical Labs
    David Shiembob, MBA, C (ASCP) CM, ARUP Laboratories, Salt Lake City, UT
  • Strategies for Addressing the Workforce Shortage
    Frederick Strathmann, PhD, MBA, DABCC (CC, TC), MOBILion Systems, Warrington, PA

33105 Heavy Metal and Elemental Toxicity in Humans: Sources of Exposure, Role of Laboratory Medicine, and Case Reports
Moderator: Paul Jannetto, PhD, DABCC, MT (ASCP), FAACC, Mayo Clinic, Rochester, MN
Speaker(s):

  • Usual and Unusual Sources of Exposure to Toxic Elements: How to Minimize Such Exposure and Treatment Strategies
    Amitava Dasgupta, PhD, DABCC, University of Kansas Medical Center, Lenexa, KS
  • Elemental Toxicity: Case Reports and the Role of Laboratory Testing
    Paul Jannetto, PhD, DABCC, MT (ASCP), FAACC, Mayo Clinic, Rochester, MN (permission withheld by speaker)

33106 A Guide to Interpreting Complex Urine, Umbilical Cord, Meconium, and Hair Toxicology Cases
Moderator: Joe El-Khoury, PhD, DABCC, FAACC, Yale University, West Haven, CT
Speaker(s):

  • Urine Trouble: Interpreting Complex Urine Toxicology Cases
    Joe El-Khoury, PhD, DABCC, FAACC, Yale University, West Haven, CT
  • In Utero Drug Exposure: The Scoop on Umbilical Cord and Poop (Meconium)
    Kamisha Johnson-Davis, PhD, MT (ASCP), DABCC, FAACC, ARUP Laboratories/University of Utah School of Medicine, Salt Lake City, UT
  • Combing Out the Biases in Hair Toxicology Testing
    Jacqueline Hubbard, PhD, DABCC, C (ASCP), Three Rivers Diagnostics, Oakdale, PA

33107 Multiple Sclerosis: Beyond Oligoclonal Banding
Moderator: Maria Alice Willrich, PhD, DABCC, FAACC, Mayo Clinic, Rochester, MN
Speaker(s):

  • A Clinical Perspective on Multiple Sclerosis: Diagnosis, Prognosis, and Treatment
    W. Oliver Tobin, MBBCh, BAO, PhD, Mayo Clinic, Rochester, MN
  • Immunoglobulin Kappa Light Chains as an Alternative to Oligoclonal Banding for Diagnosis of Multiple Sclerosis
    Harald Hegen, PD, MD, PhD, Medical University of Innsbruck, Innsbruck (Austria)
  • Monitoring Multiple Sclerosis: The Role of Neurofilaments Light Chain
    Joshua Bornhorst, PhD, DABCC, Mayo Clinic, Rochester, MN

33108 Reducing Waste, Creating Efficiencies, and Increasing Quality of Patient Care: A Case Study Review of Common Preanalytical Practices and How Small Changes Create a Big Impact
Moderator: Kacy Peterson, MBA, MLS (ASCP), DLM (ASCP), Avera Health, Sioux Falls, SD
Speaker(s):

  • Evaluating “Rainbow” Draws and Extra Tube Collection: Efficient and Convenient, or Wasteful and Unsafe?
    Christine Snozek, PhD, DABCC, FAACC, Mayo Clinic, Phoenix, AZ
  • How Important is “Clean Catch” in Urine Culture Testing? How One Hospital Avoided Millions with Improved Collection and Decreased Culture Contamination
    Kacy Peterson, MBA, MLS (ASCP), DLM (ASCP), Avera Health, Sioux Falls, SD
  • The Building Blocks of Blood Culture Collection: Can a <1% Contamination Rate be Met?
    Jessica DesLauriers, MBA, MLS (ASCP), Avera McKennan Hospital, Harrisburg, SD

33109 Clinical Assay Issues: What Endocrinologists Will Ask You
Moderator: David Sacks, MB, ChB, FRCPath, National Institutes of Health, Bethesda, MD
Speaker(s):

  • New Renin and Aldosterone Assays in the Diagnosis of Primary Aldosteronism
    Michael Stowasser, MBBS, FRACP, PhD, University of Queensland/Princess Alexandra Hospital, Woolloongabba, QLD (Australia)
  • Interpreting Challenging Prolactin Results
    Anthony Heaney, MD, PhD, University of California, Los Angeles, Los Angeles, CA
  • Endocrine Testing in Transgender Individuals
    Jenna Sarvaideo, DO, Medical College of Wisconsin, Milwaukee, WI

33110 Academy Distinguished Abstracts: Innovative Applications for Today and Emerging Discoveries for Tomorrow (permission pending)
Moderator:
Yusheng Zhu, PhD, DABCC, Pennsylvania State University Hershey Medical Center, Hershey, PA
Speaker(s):

  • An Equation based on the Standard Lipid Panel for Calculating Low-Density Lipoproteins-Triglycerides
    Anna Wolska, MS, PhD, FAHA, National Heart, Lung, and Blood Institute, Bethesda, MD
  • An R Shiny App for Automated Peak Deconvolution, Interpretation, and Quantitation of Monoclonal Proteins Using Capillary Electrophoresis Immunotyping Data
    Steven Cotten, PhD, DABCC, NRCC, FAACC, University of North Carolina at Chapel Hill, Chapel Hill, NC
  • Beta-Hydroxybutyrate/Acetoacetate Ratio as Indicator for Mitochondrial Diseases Utilizing a Novel LC-MS/MS Based Ketone Body Panel
    Robin Kemperman, PhD, Children's Hospital of Philadelphia, Philadelphia, PA
  • Accurate and Early Detection of Colorectal Cancer Using a Multilocus DNA Methylation Markers-Based Testing in Peripheral Blood
    Chuanxin Wang, MD, PhD, The Second Hospital of Shandong University, Jinan, Shandong (China)

33221 Clinical Capacity Building in Developing Countries
Moderator: Steven Cotten, PhD, DABCC, NRCC, FAACC, University of North Carolina at Chapel Hill, Chapel Hill, NC
Speaker(s):

  • Innovations in Specimen Collection and Transport in Remote Areas
    Catherine Omosule, PhD, DABCC, NRCC, Washington University in St. Louis, Saint Louis, MO
  • Building Laboratory Capacity in Developing Countries
    Joan-Miguel Balada-Llasat, PharmD, PhD, DABMM, The Ohio State University Wexner Medical Center, Columbus, OH
  • Working Hand-in-Hand with the Laboratory to Develop Workflows for Patient Management and Infection Control in Developing Countries
    Shu-Hua Wang, MD, MPH, PharmD, The Ohio State University, Columbus, OH

33222 Making Meaningful Medical Decisions by Incorporating Point-of-Care Testing: Case Based Discussions for Thoughtfully Implementing Point-of-Care Testing in Various Settings
Moderator: Jeanne Mumford, BS, MLS (ASCP), Johns Hopkins Hospital, Baltimore, MD
Speaker(s):

  • Making Point-of-Care Testing Decisions Across Your Healthcare System Using a Clinical Committee
    Jamie Acero, MHA, BS, CPP, University of Pittsburgh Medical Center, Pittsburgh, PA
  • Use Case Scenarios of a Variety of Point-of-Care Tests: Successes and Failures Based on Project Outcomes
    Meaghan Gladstone, , University of Pittsburgh Medical Center, Pittsburgh, PA
  • Meaningful Use of Point-of-Care Testing to Meet Clinical Needs in Underserved Populations
    William Clarke, PhD, MBA, DABCC, FAACC, Johns Hopkins University School of Medicine, Baltimore, MD

33223 External Quality Assessment and Alternative Assessment in Molecular Diagnostics: Findings from an IFCC Survey
Moderator: Deborah Payne, PhD, MT (ASCP), DABMM, DABCC, FAACC, CPDP Consulting LLC, Lakewood, CO
Speaker(s):

  • Results from an IFCC C-MD International Survey on EQA
    Parviz Ahmad-Nejad, MD, University of Witten/Herdecke, Wuppertal (Germany)
  • Alternate Assessment for Molecular Diagnostics: Pathway to Quality Assurance for LDTs and Rare Analytes
    Aldo Vacaflores, PhD, MLS (ASCP), Plexus Laboratorio, La Paz (Bolivia)

33224 Reimagining Laboratory Operations: Harnessing Technology to Do More Work
Moderator: Simone Arvisais-Anhalt, MD, University of California, San Francisco, San Francisco, CA
Speaker(s):

  • Self-Service with Support: Reporting Needs and Solutions in the Clinical Laboratory
    Michelle Stoffel, MD, PhD, University of Minnesota/M Health Fairview, W, Roseville, MN
  • Problem Solving with Python: A Case Series
    Jacob Spector, MD, Boston Children’s Hospital, Boston, MA
  • Automating Workflows: Dream or Reality?
    Simone Arvisais-Anhalt, MD, University of California, San Francisco, San Francisco, CA

33225 The Lab and Biomarkers in Cardiometabolic Clinical Trials: What Are Their Roles and What Are the Gains?
Moderator: Paul Welsh, PhD, MSc, BSc (Hons), University of Glasgow, Glasgow (United Kingdom)
Speaker(s):

  • Biomarkers as Entry Criteria and Surrogate Outcomes for Cardiovascular Clinical Trials
    David Berg, MD, MPH, Brigham and Women's Hospital, Boston, MA
  • Can Biomarkers Help Us Understand Novel Drug Mechanisms of Action?
    Paul Welsh, PhD, MSc, BSc (Hons), University of Glasgow, Glasgow (United Kingdom)
  • The Lab as a Hub for Clinical Trials: The HIGH-STEACS and HiSTORIC Experience and Beyond
    Atul Anand, MD, PhD, University of Edinburgh, Edinburgh (United Kingdom)

33226 Balancing Laboratory Workload and Costs to Patient Care: Method Selection and Testing Algorithm in Monoclonal Gammopathy Management
Moderator: Jing Cao, PhD, DABCC, FAACC, University of Texas Southwestern Medical Center, Dallas, TX
Speaker(s):

  • Selective Reflex to Immunofixation with Restricted Testing Frequency for Patient Population with Large Number of Stem Cell Transplants
    Alagarraju Muthukumar, PhD, MSc, DABCC, University of Texas Southwestern Medical Center, Dallas, TX
  • Automated Workflow with Immunotyping in a Large Academic Health Center Core Lab
    J Shirley Li, MD, PhD, DABCC, NRCC, FCACB, The Ohio State University Wexner Medical Center, Columbus, OH
  • Order Set Building and Test Utilization in Monitoring Patients with Monoclonal Gammopathy
    David Grenache, PhD, DABCC, MT (ASCP), TriCore Reference Laboratories, Albuquerque, NM

33227 Infectious Disease Serology: Are You Still Ordering That Test?
Moderator: Sarah Wheeler, PhD, FAACC, University of Pittsburgh Medical Center, Pittsburgh, PA
Speaker(s):

  • What Does this Mean? Understanding Test Results for Infectious Diseases
    Patricia Slev, MD, PhD, DABCC, ARUP Laboratories/University of Utah School of Medicine, Salt Lake City, UT
  • Infectious Disease Labs We Order and Then Regret
    Elitza Theel, PhD, D(ABMM), Mayo Clinic, Rochester, MN
  • Do You Really Need That Infectious Disease Test?
    Sarah Wheeler, PhD, FAACC, University of Pittsburgh Medical Center, Pittsburgh, PA

33228 Optimal Testing: AACC’s Guide to Lab Test Utilization
Moderator: Yusheng Zhu, PhD, DABCC, Pennsylvania State University Hershey Medical Center, Hershey, PA
Speaker(s):

  • Optimal Lab Testing for Celiac Diseases: Is Antigliadin Antibody Still Indicated?
    Fang Wu, PhD, DABCC, FCACB, FAACC, Saskatchewan Health Authority/University of Saskatchewan, Saskatoon, SK (Canada)
  • Laboratory Test Utilization: Utility of Ferritin Test in Pediatrics for Iron Deficiency
    Sridevi Devaraj, PhD, DABCC, FRSC, FAACC, Texas Children's Hospital/Baylor College of Medicine, Houston, TX

33229 Compliance vs Care: Providing the Highest Quality Medicine on Unsteady Legal Ground (permission withheld by speakers)
Moderator: Dina Greene, PhD, DABCC, LetsGetChecked, Burien, WA
Speaker(s):

  • Rapidly Changing Barriers to Abortion Care and Safe Pregnancy Termination
    Abbey Hardy Fairbanks, MD, University of Iowa Hospitals and Clinics, Iowa City, IA
  • Protecting Transgender Youth from Governmental Policy
    Janet Black, MSN, APRN, FNP-C, QMed, LLC, Decatur, GA
  • Reproductive Rights and Gender Affirming Health Care: Juggling State and Federal Laws and Policy to Engage Providers and Deliver Optimum Patient Care
    Ashley Bogle, Esq, Health New England, Springfield, MA

33230 The Clinical Laboratory’s Role in Ensuring Sample Quality Prior to Testing
Moderator: Dustin Bunch, PhD, DABCC, Nationwide Children's Hospital, Columbus, OH
Speaker(s):

  • Hemolysis, Icterus and Lipemia: New Approaches to Dealing with Old Foes
    Joe El-Khoury, PhD, DABCC, FAACC, Yale University, West Haven, CT
  • Pediatric Complexity: How to Manage HIL Instrument Errors
    Dustin Bunch, PhD, DABCC, Nationwide Children's Hospital, Columbus, OH
  • Red Rule! Teaching Nurses Proper Sample Identification
    Eugenio Zabaleta, PhD, OhioHealth Mansfield Hospital, Mansfield, OH

34101 Laboratory Medicine Career Toolkit: What We Were Never Taught (permission withheld by speakers)
Moderator: Sarah Hackenmueller, PhD, DABCC, FAACC, Providence Health & Services Oregon, Portland, OR
Speaker(s):

  • Time Management Tools for the Laboratory Professional
    Joe El-Khoury, PhD, DABCC, FAACC, Yale University, West Haven, CT
  • Work-Life Harmony
    Sarah Wheeler, PhD, FAACC, University of Pittsburgh Medical Center, Pittsburgh, PA
  • Building Resiliency
    Sarah Hackenmueller, PhD, DABCC, FAACC, Providence Health & Services Oregon, Portland, OR

34102 Top-Down Mass Spectrometry: A Next Era in Clinical Mass Spectrometry?
Moderator: Ruben Luo, PhD, DABCC, Stanford University, Palo Alto, CA
Speaker(s):

  • Top-Down Mass Spectrometry for Clinical Testing: Sample Preparation and Separation Techniques with Application Cases of ß2-Transferrin and Hemoglobin Variants
    Ruben Luo, PhD, DABCC, Stanford University, Palo Alto, CA
  • Application of Top-down Mass Spectrometry to M-Proteins: New Findings Based on Proteoforms
    David Murray, MD, PhD, MBA, MT (ASCP), Mayo Clinic, Rochester, MN
  • Top-Down Proteomics for Clinical Diagnosis and Cardiac Precision Medicine
    Ying Ge, PhD, University of Wisconsin-Madison, Madison, WI

34103 Molecular Respiratory Testing Considerations in a Post-Pandemic Era
Moderator: Brian Mochon, PhD, DABMM, University of Arizona/Banner Health, Phoenix, AZ
Speaker(s):

  • Available Molecular Respiratory Tests and Diagnostic Stewardship Considerations
    Brian Mochon, PhD, DABMM, University of Arizona/Banner Health, Phoeniz, AZ
  • Classifying the Patient Populations That Benefit the Most from a Molecular Single Plex, 3-5 Multiplex, or a Larger Syndromic Panel for Respiratory Diseases
    Payal Patel, MD, MPH, Intermountain Healthcare, Salt Lake City, UT
  • Data Driven Case Presentations That Support Optimal Respiratory Testing Algorithms
    Matthew Binnicker, PhD, Mayo Clinic, Washington, DC

34104 2023 Data Analytics Competition: Forecasting Future Preanalytical Errors
Moderator: Mark Zaydman, MD, PhD, Washington University in St. Louis, Saint Louis, MO
Speaker(s):

  • Help with Hemolysis: An AACC Data Analytics Competition
    Mark Zaydman, MD, PhD, Washington University in St. Louis, Saint Louis, MO
  • Blood and Bytes: Reducing Sample Quality Errors in Clinical Laboratories Using Data Science
    Eric Olson, MS, Babson Diagnostics, Inc, Austin, TX

34105 High-Sensitivity Troponin: Strategies and Future Opportunities to Improve Patient Care
Moderator: Kristin Aakre, MD, PhD, Haukeland University Hospital, Bergen (Norway)
Speaker(s):

  • High Sensitivity Point-of-Care Troponin Assays Are Coming: Expectations and Pitfalls
    Kristin Aakre, MD, PhD, Haukeland University Hospital, Bergen (Norway)
  • Integration of Cardiac Biomarkers into Artificial Intelligence Tools
    Richard Body, MB ChB, MRCSEd, FRCEM, PhD, University of Manchester, Manchester (United Kingdom)
  • Could We Improve the Diagnostic Specificity of Troponins Assays?
    Steven Meex, PhD, Maastricht University Medical Center, Maastricht (Netherlands)

34106 Speed Dating for Analytical Interferences: Is There an App for That? (session not recorded)
Moderator: Mark Marzinke, PhD, DABCC, FAACC, Johns Hopkins University, Baltimore, MD
Speaker(s):

  • T(r)inder: Meeting and Breaking Up with Enzymatic Interferents
    Mark Marzinke, PhD, DABCC, FAACC, Johns Hopkins University, Baltimore, MD
  • (G)Uber: What is that messing up my immunoassay?
    Jane Dickerson, PhD, DABCC, Seattle Children's Hospital, Seattle, WA
  • TikTox: Identify Drug Assay Interferents When the Clock Is Ticking
    Alec Saitman, PhD, ASCP, DABCC, Providence Regional Laboratories, Portland, OR

34107 Leveraging Blood-Based Biomarkers to Enhance the Precision of Traumatic Brain Injury Evaluation and Management
Moderator: Frederick Korley, MD, PhD, University of Michigan, Ann Arbor, MI
Speaker(s):

  • A Summary of the Evidence Supporting the Clinical Use of GFAP and UCH-L1
    Nathan Roberts, MD, PhD, University of Michigan Medical School, Ann Arbor, MI
  • A Pragmatic Validation of the Diagnostic Accuracy of GFAP and UCH-L1 at the University of Michigan
    Nathan Roberts, MD, PhD, University of Michigan Medical School, Ann Arbor, MI
  • University of Michigan’s Approach to the Clinical Implementation of GFAP and UCH-L1: Lessons Learned
    Frederick Korley, MD, PhD, University of Michigan, Ann Arbor, MI

34108 Direct-to-Consumer and Direct Access Testing: A Discussion from Clinical, Laboratory, and Informatics Viewpoints
Moderator: Julie Shaw, PhD, FCACB, Eastern Ontario Regional Laboratory Association, University of Ottawa, Ottawa Hospital, Ottawa, ON (Canada)
Speaker(s):

  • A Clinical Perspective
    Julie Shaw, PhD, FCACB, Eastern Ontario Regional Laboratory Association, University of Ottawa, Ottawa Hospital, Ottawa, ON (Canada)
  • An Informatics Perspective
    Michelle Stoffel, MD, PhD, University of Minnesota/M Health Fairview, W, Roseville, MN
  • A Laboratory Perspective
    Matthias Orth, MD, PhD, Vinzenz von Paul Kliniken gGmbH Marien Hospital, D-70199 Stuttgart (Germany)

34109 Infectious Diseases Serology Potpourri: Diagnosis of Common Congenital and Not So Common Viral Hepatitis infections
Moderator: Victoria Zhang, PhD, MBA, DABCC, FAACC, University of Rochester Medical Center, Rochester, NY
Speaker(s):

  • Is it ToRCH or SCORCH? Update on Congenital Infections and How to Diagnose Them
    Elitza Theel, PhD, D(ABMM), Mayo Clinic, Rochester, MN
  • Diagnosis and Management for the Not So Common Causes of Viral Hepatitis
    Patricia Slev, MD, PhD, DABCC, ARUP Laboratories/University of Utah School of Medicine, Salt Lake City, UT

34110 Continuous Glucose Monitoring Devices: A Friend or Foe to Clinical Laboratories
Moderator: Nam Tran, PhD, MS, HCLD (ABB), CLS, MLS (ASCP) cm, FAACC, University of California, Davis, Davis, CA
Speaker(s):

  • History of Glucose Monitoring: A Review of Continuous Glucose Monitoring Devices
    Catherine Omosule, PhD, DABCC, NRCC, Washington University in St. Louis, Saint Louis, MO
  • CGM Use in Diabetes: As Part of Automated Insulin Delivery and as a Tool to Manage Anti-hyperglycemic Therapies
    Andrew Ahmann, MD, Oregon Health and Science University, Portland, OR
  • Updates from the AACC Taskforce for CGM Device Usage Guidance
    Nichole Korpi-Steiner, PhD, DABCC, FAACC, University of North Carolina, Chapel Hill, NC

34111 Advocacy: How Lab Medicine Experts Improve and Positively Impact Public Health
Moderator: Carmen Wiley, PhD, DABCC, FAACC, Incyte Diagnostics, Spokane Valley, WA
Speaker(s):

  • Did You Say, VALIDation?”: What VALID Was, Why It Was Harmful, and How It May Impact the Future of Lab Medicine
    Carmen Wiley, PhD, DABCC, FAACC, Incyte Diagnostics, Spokane Valley, WA
  • PEACC Tackles VALID: Assessing This Proposed LDT Regulation
    Patricia Jones, PhD, DABCC, FAACC, University of Texas Southwestern Medical Center, Dallas, TX
  • Advocacy: The Pen, the Preaching, the Process, All Promoting Best Practice
    Dennis Dietzen, PhD, DABCC, FAACC, Washington University School of Medicine, Saint Louis, MO
  • I Must Have Missed That Day in Training: The Impact of Policy and Advocacy in Laboratory Medicine
    Christina Lockwood, PhD, DABCC, DABMGG, University of Washington, Seattle, WA

34221 Chemistry Confessions: Constructive Conflict Resolution with Case Studies
Moderator: William Clarke, PhD, MBA, DABCC, FAACC, Johns Hopkins University School of Medicine, Baltimore, MD
Speaker(s):

  • Conflict in Organizational Behavior: Causes, Consequences, and Confessions
    Jane Dickerson, PhD, DABCC, Seattle Children's Hospital, Seattle, WA
  • Strategies for Effective Management of Conflict and Difficult Conversations
    William Clarke, PhD, MBA, DABCC, FAACC, Johns Hopkins University School of Medicine, Baltimore, MD
  • What Kind of Bird Are You? Navigating Communication Styles and Personality Types to Get Results
    Frederick Strathmann, PhD, MBA, DABCC (CC, TC), MOBILion Systems, Warrington, PA

34222 Emerging Technologies for the Next-Generation of Point-of-Care Testing
Moderator: James Nichols, PhD, DABCC, FAACC, Vanderbilt University Medical Center, Nashville, TN
Speaker(s):

  • Point-of-Care Testing: The Disruption of Traditional Laboratory Practices to Meet Evolving Patient Needs
    James Nichols, PhD, DABCC, FAACC, Vanderbilt University Medical Center, Nashville, TN
  • Implementation of Nucleic-acid Testing (NAT) Devices in Hospital Settings
    Peter Luppa, MD, Klinikum rechts der Isar, Technische Universität München, München (Germany)
  • Standardization Process of Continuous Glucose Monitoring: Traceability and Performance
    Guido Freckmann, MD, Institute for Diabetes Technology GmbH, Ulm, Germany, Ulm (Germany)

34223 Difficulties in Reporting Complex Coagulation Results in the Era of New Anticoagulants
Moderator: Morayma Reyes-Gil, MD, PhD, Cleveland Clinic, Cleveland Heights, OH
Speaker(s):

  • Practical Tips on Reporting of Coagulation Results: Special Emphasis on Pediatric Cases on Anticoagulants
    Catherine Hayward, MD, PhD, FRCP, McMaster University, Hamilton, ON (Canada)
  • Utility of Anticoagulant Monitoring from Old to New Anticoagulants: How and When to Monitor Using New Technology to Detect Anticoagulants
    Geoffrey Wool, MD, PhD, University of Chicago, Chicago, IL
  • Difficulties in Reporting Lupus Anticoagulant Results: DOAC Interferences and How to Interpret Mixing Studies Specially When Patients Are on Anticoagulants
    Morayma Reyes-Gil, MD, PhD, Cleveland Clinic, Cleveland Heights, OH

34224 Generalizability of Machine Learning Models in Clinical Laboratory Medicine
Moderator: He Yang, PhD, DABCC, FAACC, Weill Cornell Medicine, New York, NY
Speaker(s):

  • AACC PTHrP Data Challenge and Beyond: Strategies to Evaluate and Improve Machine Learning Model Generalizability
    He Yang, PhD, DABCC, FAACC, Weill Cornell Medicine, New York, NY
  • Challenges and Strategies for Engineering Machine Learning Algorithms That Generalize across Patient Subgroups
    Vahid Azimi, MD, Washington University School of Medicine, Saint Louis, MO
  • Considerations for Building Generalizable Clinical Machine Learning Models
    Fei Wang, PhD, Weill Cornell Medicine, New York, NY

34225 Clinical Chemistry Journal: Hot Topics in Laboratory Medicine
Moderator: Jason Park, MD, PhD, DABCC, University of Texas Southwestern Medical Center, Dallas, TX
Speaker(s):

  • Role of Glycated Albumin in the Diagnosis and Management of Diabetes Mellitus
    Elizabeth Selvin, PhD, MPH, Johns Hopkins University, Baltimore, MD
  • Using Troponins for Early Rule-Out of Non-ST Elevation Myocardial Infarction and Unstable Angina Pectoris: Is It Possible?
    Kristin Aakre, MD, PhD, Haukeland University Hospital, Bergen (Norway)
  • Toward Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis
    Wolfgang Wagner, MD, PhD, RWTH Aachen University Medical School, Aachen (Germany)

34226 New ADA/ACC/HFSA Recommendations to Utilize Cardiac Biomarkers to Identify Risk of Heart Failure in People with Diabetes
Moderator: Petr Jarolim, MD, PhD, Brigham and Women's Hospital, Boston, MA
Speaker(s):

  • Optimal Approaches to Heart Failure Prevention Using Cardiac Biomarkers and Clinical Risk Scores: Clinical Scenarios
    Ambarish Pandey, MD, University of Texas Southwestern Medical Center, Dallas, TX
  • A Case-Based Approach to Understanding the Impact on the Practice of Medicine and Primary Care Providers
    Jennifer Zreloff, MD, Emory University School of Medicine, Atlanta, GA
  • Optimal Biomarker Cutoffs and Operational Impact on Clinical Laboratories
    Petr Jarolim, MD, PhD, Brigham and Women's Hospital, Boston, MA

34227 Revisiting Serum Free Light Chain Reference Intervals by Retrospective Data Analytics and Unsupervised Machine Learning
Moderator: Lee Schroeder, MD, PhD, University of Michigan/InheRET, inc., Ann Arbor, MI
Speaker(s):

  • The Serum Free Light Chain Diagnostic Interval in Doubt
    David Keren, MD, MS, The University of Michigan, Ann Arbor, MI
  • Using Existing Health Care Data for the Characterization of Serum Free Light Chain Reference Intervals and Decision Limits
    Lee Schroeder, MD, PhD, University of Michigan/InheRET, inc., Ann Arbor, MI
  • A Novel Serum Free Light Chain Metric Based on Unsupervised Machine Learning To Reduce Renal Function Interference
    Mark Zaydman, MD, PhD, Washington University in St. Louis, Saint Louis, MO

34228 AACC Academy’s Clinical Laboratorian and Clinician Conversations: In Vitro Fertilization and Ectopic Pregnancy
Moderator: Yusheng Zhu, PhD, DABCC, Pennsylvania State University Hershey Medical Center, Hershey, PA
Speaker(s):

  • Advances in IVF and How Clinical Laboratorians Help Us Manage IVF Patients
    Joie Guner, MD, MSc, MSCI, Keck School of Medicine of USC, Pasadena, CA
  • Laboratory Tests for IVF: Current Status and Emerging Biomarkers
    Yusheng Zhu, PhD, DABCC, Pennsylvania State University Hershey Medical Center, Hershey, PA
  • Integrating Essential Laboratory Testing into the Workup of an Emergent Patient with Suspected Ectopic Pregnancy
    Daniel Moore, MD, University of Kentucky, Lexington, KY
  • The Role of the Clinical Laboratorian in the Diagnosis and Monitoring of Ectopic Pregnancy: Communication Is Key
    Alison Woodworth, PhD, DABCC, FAACC, University of Kentucky, Cincinnati, OH

34229 Diamonds are Forever: 75 Years of Laboratory Medicine
Moderator: Robert Rej, PhD, University at Albany State University of New York, Albany, NY
Speaker(s):

  • The AACC Annual Scientific Meeting at 75: How We Got Here from There
    Robert Rej, PhD, University at Albany State University of New York, Albany, NY
  • Immunoassays Past and Present: From Impossible Manual Tests to 21st Century Automation
    Richard Baltaro, MD, PhD, ASCP, FAACC, East Carolina University School of Medicine, Winterville, NC
  • Innovation, Technology, and Regulation: The Advent of the Modern Medical Laboratory
    David Alter, MD, MPH, DABCC, FAACC, Emory University, Atlanta, GA

35101 A Roadmap to Implementing Alzheimer’s Disease Biomarkers in Your Laboratory
Moderator: Melissa Budelier, PhD, DABCC, TriCore Reference Laboratories, Albuquerque, NM
Speaker(s):

  • Clinical Implementation of CSF Alzheimer’s Disease Biomarkers: The United States experience
    Alicia Algeciras-Schimnich, PhD, DABCC, Mayo Clinic, Rochester, MN
  • Clinical Implementation of CSF Alzheimer’s Disease Biomarkers: The Canadian experience
    Mari DeMarco, PhD, DABCC, FAACC, St. Paul's Hospital, Vancouver, BC (Canada)
  • Future Implementation of Blood-Based Biomarkers for Alzheimer’s Disease and Related Disorders
    Melissa Budelier, PhD, DABCC, TriCore Reference Laboratories, Albuquerque, NM

35102 Choosing Targets for Laboratory Stewardship Programs: Results of a Cross-Institutional Survey and Lessons to Be Learned from Clinical Quality Measure Databases
Moderator: Lee Schroeder, MD, PhD, University of Michigan/InheRET, inc., Ann Arbor, MI
Speaker(s):

  • The Current State and Focus of Laboratory Stewardship Programs: Results of a National Survey.
    Grace Kroner, PhD, DABCC, Cleveland Clinic, Cleveland, OH
  • The Landscape of Clinical Quality Measure Databases and Implications for Laboratory Stewardship Programs: A Call to Harmonize and Benchmark Measures
    Lee Schroeder, MD, PhD, University of Michigan/InheRET, inc., Ann Arbor, MI

35103 The Clinical Laboratory as a Catalyst in Population Health: Amplifying the Transition to Risk-Based Health Care in Integrated Health Systems
Moderator: James Crawford, MD, PhD, Northwell Health, Greenvale, NY
Speaker(s):

  • Why the Clinical Laboratory is a Catalyst for Population Health
    James Crawford, MD, PhD, Northwell Health, Greenvale, NY
  • A Laboratory Initiated Care Model: Chronic Kidney Disease
    Mark Fung, MD, PhD, University of Vermont Medical Center, Burlington, VT

35104 Fibrinogen: The Entangled Knot of the Clot
Moderator: Neil Harris, MD, FAACC, University of Florida, Gainesville, FL
Speaker(s):

  • Fibrinogen and Hemostasis
    William Winter, MD, DABCC, FAACC, University of Florida, Gainesville, FL
  • Measurement of fibrinogen in plasma
    Maximo Marin, MD, University of Florida, Gainesville, FL
  • Acquired and Inherited Disorders of Fibrinogen
    Neil Harris, MD, FAACC, University of Florida, Gainesville, FL

35105 Pediatric Lipid Screening: The Heart of the Matter
Moderator: Stephen Roper, PhD, DABCC, Washington University School of Medicine, Saint Louis, MO
Speaker(s):

  • Evolution of Pediatric Lipid Screening Recommendations: The Lab’s Role in Promoting Universal Testing
    Stephen Roper, PhD, DABCC, Washington University School of Medicine, Saint Louis, MO
  • Laboratory-Driven Interventions to Improve Lipid Screening and FH Detection in Pediatric Populations
    Zita Hubler, MD, PhD, Washington University School of Medicine, St. Louis, MO

35106 Testing the Population Towards Eliminating Inequities in STIs: A Case-Based Toolkit
Moderator: Nikolina Babic, PhD, DABCC, FAACC, Medical University of South Carolina, Charleston, SC
Speaker(s):

  • A Pink Elephant of STIs That is Not Going Anywhere!
    Vera Tesic, MD, MS, DABMM, University of Chicago, Chicago, IL
  • Point-of-Care Testing for STI Detection: The Answer to All Our Troubles?
    Nikolina Babic, PhD, DABCC, FAACC, Medical University of South Carolina, Charleston, SC
  • Out in the Real World: HIV and Syphilis
    Vera Tesic, MD, MS, DABMM, University of Chicago, Chicago, IL
  • Out in the Real World: Chlamydia and Gonorrhea
    Nikolina Babic, PhD, DABCC, FAACC, Medical University of South Carolina, Charleston, SC

35107 Biochemical and Molecular Insights into Newborn Screening Disorders Both Old and New
Moderator: Stanley Lo, PhD, DABCC, FAACC, Children's Wisconsin, Milwaukee, WI
Speaker(s):

  • Clinical Testing Tribulations of New Disorders Added to Newborn Screening: Biochemical Genetics Evaluations of Lysosomal and Peroxisomal Disorders
    Anna Scott, PhD, Seattle Children's Hospital, Seattle, WA
  • Next Generation Newborn Screening: Increasing Importance and Complexity of Molecular Testing
    Erika Beckman, MS, CGC, Seattle Children’s Hospital, Seattle, WA